A detailed history of Stokes Family Office, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Stokes Family Office, LLC holds 39,003 shares of BMY stock, worth $2.27 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
39,003
Previous 40,869 4.57%
Holding current value
$2.27 Million
Previous $1.7 Million 18.92%
% of portfolio
0.23%
Previous 0.2%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$39.66 - $51.75 $74,005 - $96,565
-1,866 Reduced 4.57%
39,003 $2.02 Million
Q2 2024

Jul 05, 2024

SELL
$40.25 - $52.99 $14,329 - $18,864
-356 Reduced 0.86%
40,869 $1.7 Million
Q1 2024

May 06, 2024

BUY
$47.98 - $54.4 $37,472 - $42,486
781 Added 1.93%
41,225 $2.24 Million
Q4 2023

Feb 06, 2024

SELL
$48.48 - $57.85 $67,435 - $80,469
-1,391 Reduced 3.32%
40,444 $2.08 Million
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $14,356 - $16,053
248 Added 0.6%
41,835 $2.43 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $18,475 - $20,514
290 Added 0.7%
41,587 $2.66 Million
Q1 2023

May 08, 2023

SELL
$65.71 - $74.53 $21,092 - $23,924
-321 Reduced 0.77%
41,297 $2.86 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $51,291 - $60,736
749 Added 1.83%
41,618 $2.99 Million
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $85 - $50,560
658 Added 1.64%
40,869 $2.91 Million
Q2 2022

Aug 05, 2022

BUY
$72.62 - $79.98 $50,035 - $55,106
689 Added 1.74%
40,211 $3.1 Million
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $10,943 - $13,122
178 Added 0.45%
39,522 $2.89 Million
Q4 2021

Feb 15, 2022

SELL
$53.63 - $62.52 $47,248 - $55,080
-881 Reduced 2.19%
39,344 $2.45 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $32,602 - $38,189
-551 Reduced 1.35%
40,225 $2.38 Million
Q2 2021

Aug 12, 2021

BUY
$61.91 - $67.42 $47,113 - $51,306
761 Added 1.9%
40,776 $2.73 Million
Q1 2021

May 13, 2021

BUY
$59.34 - $66.74 $67,766 - $76,217
1,142 Added 2.94%
40,015 $2.53 Million
Q4 2020

Feb 10, 2021

BUY
$57.74 - $65.43 $22,865 - $25,910
396 Added 1.03%
38,873 $2.41 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $47,954 - $53,139
835 Added 2.22%
38,477 $2.32 Million
Q2 2020

Aug 11, 2020

BUY
$54.82 - $64.09 $40,950 - $47,875
747 Added 2.02%
37,642 $2.21 Million
Q1 2020

May 12, 2020

BUY
$46.4 - $67.43 $5,104 - $7,417
110 Added 0.3%
36,895 $2.06 Million
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $1.81 Million - $2.36 Million
36,785 New
36,785 $2.36 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Stokes Family Office, LLC Portfolio

Follow Stokes Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stokes Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stokes Family Office, LLC with notifications on news.